Clinical Outcomes and Resource Utilization Over 10 Years of Institutional Treatment Practice Changes in Pediatric Asthma Exacerbations
Pediatric Pulmonology · 2026-11 · 61 (11)
DOI: 10.1002/ppul.71921 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 13.11.2026. Verfasst von Dokfai Kaewwaew und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand. Hauptthemen laut MEDLINE: Asthma, Bronchodilator Agents, Oxygen Inhalation Therapy. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate changes in clinical outcomes and resource utilization associated with changes in institutional practice for the management of acute asthma exacerbations in children over a 10‐year study period.
Methods
This retrospective cohort study included children aged 2–15 years hospitalized for moderate‐to‐severe asthma exacerbations from 2016 to 2025 ( n = 329). Patients were categorized according to the institutional treatment strategy implemented during different periods of the study; conventional oxygen therapy with bronchodilator delivery using a jet nebulizer (JN group), n = 196), high flow nasal cannula oxygen therapy with bronchodilator via JN (HFNC‐JN group; n = 80), and HFNC with an in‐line vibrating mesh nebulizer (HFNC‐VN group; n = 53). Inverse probability of treatment weighting was used to adjust for baseline differences among the groups.
Results
The median hospital length of stay differed significantly among the JN, HFNC‐JN, and HFNC‐VN groups: 59 (interquartile range [IQR], 44, 71), 64 (IQR, 55, 91), and 78 (IQR, 55, 101) h, respectively ( p < 0.001). The corresponding percent change in respiratory rate at 24 h differed significantly: −12.5% (IQR, −22.2%, −4.9%), −22.2% (IQR, −31.0%, 0.0%), and −19.6% (IQR, −29.4%, −10.8%) ( p = 0.038). The HFNC‐VN group received higher cumulative salbutamol doses at 1, 6, 12, 24, and 48 h and incurred the highest treatment costs.
Conclusion
Changes in institutional treatment practices for asthma exacerbation, including oxygen therapy, respiratory support, bronchodilator administration, and weaning practices, were associated with longer hospital stays and higher total treatment costs. These findings provide real‐world evidence supporting the need for standardized treatment practices and development of evidence‐based treatment protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand.
ORCID-Profile: Dokfai Kaewwaew, Wanaporn Anuntaseree, Kanokpan Ruangnapa, Kantara Saelim, Pharsai Prasertsan, Kantisa Sirianansopa
Zitieren
APA
Kaewwaew, D., Anuntaseree, W., Ruangnapa, K., Saelim, K., Prasertsan, P., & Sirianansopa, K. (2026). Clinical Outcomes and Resource Utilization Over 10 Years of Institutional Treatment Practice Changes in Pediatric Asthma Exacerbations. Pediatric Pulmonology, 61(11). https://doi.org/10.1002/ppul.71921
Vancouver
Kaewwaew D, Anuntaseree W, Ruangnapa K, Saelim K, Prasertsan P, Sirianansopa K. Clinical Outcomes and Resource Utilization Over 10 Years of Institutional Treatment Practice Changes in Pediatric Asthma Exacerbations. Pediatric Pulmonology. 2026;61(11). doi:10.1002/ppul.71921
BibTeX
@article{Kaewwaew2026,
author = {Kaewwaew, Dokfai and Anuntaseree, Wanaporn and Ruangnapa, Kanokpan and Saelim, Kantara and Prasertsan, Pharsai and Sirianansopa, Kantisa},
title = {Clinical Outcomes and Resource Utilization Over 10 Years of Institutional Treatment Practice Changes in Pediatric Asthma Exacerbations},
journal = {Pediatric Pulmonology},
year = {2026},
volume = {61},
number = {11},
doi = {10.1002/ppul.71921}
}
EUVIMED